Bringing the PRO to fruition

May 14, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PROs, feature, patient reported outcomes, patient-reported outcomes, pharma

Patient-reported outcomes are becoming increasingly respected and valued by clinical professionals in the pursuit of improving treatment outcomes, but their …

shutterstock_273326141

Medigene and bluebird bio expand immunotherapy partnership to $1.5bn

May 14, 2018
Research and Development, Sales and Marketing Bluebird Bio, Cancer, Medigene, pharma

Medigene has announced that it has bolstered the existing partnership it has in place with US firm bluebird bio, originally …

Takeda financials show why the Shire deal was needed

May 14, 2018
Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical

After posting its financials from 2017 and its guidance for the year to come, itโ€™s clear to see why Takeda …

donald_j

Pharma unfazed by Trump price-reduction proposals

May 14, 2018
Medical Communications, Sales and Marketing PhRMA, President trump, biotech, drugs, pharma, pharmaceutical

President Trumpโ€™s speech on Friday afternoon had been long-anticipated, ever since he was elected and then hammered the pharma industry …

novartis_side_building

FDA awards first paediatric MS approval to Novartis’ Gilenya

May 14, 2018
Sales and Marketing FDA, gilenya, multiple sclerosis, pharma

The FDA has awarded approval for what it says is its first drug for the treatment of multiple sclerosis (MS) …

david_horn_solomon

Akari CEO resigns over allegations of spending company funds

May 11, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akari, appointment

Akari has lost its second CEO in 12 months after David Horn Solomon was accused of misusing the company credit …

Janssen’s Tremfya gets go-ahead from NICE in plaque psoriasis

May 11, 2018
Medical Communications, Sales and Marketing Janssen, NICE, Tremfya, UK, pharma, psoriasis

NICE, the UKโ€™s drug watchdog for the NHS, has decided that Janssenโ€™s Tremfya (guselkumab) should be used routinely through the …

top_ten

Top Ten most popular articles on Pharmafile.com this week

May 11, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, EMA, GSK, J&J, JJ, Novartis, Shire, Takeda, Valeant, biotech, drugs, pharma, pharmaceutical

Itโ€™s been a week in which one of the largest pharmaceutical takeovers in history took place and yet itโ€™s not …

roche

Roche’s Tecentriq/Cotellic combo therapy fails to impress in colorectal cancer

May 11, 2018
Medical Communications, Research and Development Cancer, Cotellic, Roche, pharma, tecentriq

Roche has been rocked by a Phase 3 weak showing from its combination Tecentriq (atezolizumab) and Cotellic (cobimetinib) in people …

AZโ€™s Fasenra stumbles in P3 for COPD

May 11, 2018
Medical Communications, Research and Development AstraZeneca, Fasenra, GSK, Nucala, biotech, drugs, pharma, pharmaceutical

AstraZenecaโ€™s Fasenra arrived later on the scene than GSK rival med, Nucala, and so it needed to quickly rack up …

dialogo

DIA โ€“ CMC Workshop

May 11, 2018
Medical Communications dia

This workshop, through plenary and parallel sessions, will focus on current challenging topics within the global pharmaceutical/biopharmaceutical arena. Attendees from …

andy_c4

C4 Therapeutics fills out C-Suite with CEO appointment

May 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing C4 Therapeutics, biotech, drugs, pharma, pharmaceutical

C4 Therapeutics has been slowly expanding since its creation in early 2016 out of the prestigious Dana-Farber Cancer Institute. Andrew …

lilly2_web

Lilly moves quickly to secure $1.6bn buyout of Armo

May 10, 2018
Medical Communications, Sales and Marketing Armo Biosciences, Eli Lilly, biotech, drugs, pharma, pharmaceutical

Armo BioSciences only went public in January but it has already been snapped up by Eli Lilly for $1.6 billion. …

cancer-vs-alzheimer-1080x810

NanoBots: The science of small to dwarf the disease

May 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Precision Medicine, nanorobots, pharma

Anjali Shukla delves into the exciting, miniature world of nanorobotics to explore how the ground-breaking technology promises to change the …

320px-human_embryonic_stem_cells_only_a

FDA launches lawsuits against stem cell clinics after patients rendered blind

May 10, 2018
Medical Communications, Sales and Marketing FDA, Stem cells, US, macular degeneration, pharma

At the request of the FDA, The US Department of Justice has launched legal action seeking to shut down stem …

soil-3301161_960_720

Lodo and Roche go digging for drug candidates, after $1bn deal

May 10, 2018
Sales and Marketing Genentech, Roche, biotech, drugs, pharma, pharmaceutical

Discovering potential therapeutics from natural sources has been a constant throughout the evolution of medicine, Lodo Therapeutics, however, has taken …

Novartisโ€™ $1.2m payment to Trumpโ€™s lawyer raises more questions than answers

May 10, 2018
Medical Communications Essential Consultants, Michael Cohen, Novartis, President trump, Trump, biotech, drugs, pharma, pharmaceutical

Novartis payment to President Trumpโ€™s personal lawyer, Michael Cohen, had seemed fairly odd from the beginning โ€“ with many asking …

pharmafile_srping_2018_cover

The new and improved Spring 2018 edition of Pharmafile is available to read online now!

May 9, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CNS, Cancer, Pharmafocus, cardiovascular, cvd, oncology, pharmafile

The Spring 2018 edition of Pharmafile, our long-running bi-annual guide to the latest trends, projections and thought leadership positions in …

joanna_shields

BenevolentAI names former UK Minister as new Group CEO

May 9, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, BenevolentAI, Facebook, UK, appointment, google

Health and drug development-focused artificial intelligence firm BenevolentAI has announced that former UK Minister for Internet Security and Safety Joanna …

The Gateway to Local Adoption Series

Latest content